In 1951 McArdle described a 30 year old male who had complained of painful muscular cramps on exercise from early childhood. A defect in the breakdown of muscle glycogen was suspected when the serum lactate and pyruvate failed to rise in blood flowing from ischaemic muscle after exercise. It was not until 1959 that Mommaerts, Illingworth, Pearson, Guillory, and Seraydatian, and Schmid and Mahler independently established the metabolic defect of this myopathy. Examination of muscle biopsy material showed an excessive glycogen content and myophosphorylase activity was absent.
Several studies of affected families have suggested that the disorder is a recessive character shown by individuals homozygous for a rare autosomal gene. The present study describes a further three related patients with this rare inherited myopathy. In addition, nine unaffected relatives were investigated in an attempt to identify the heterozygous state.
GENETIC ASPECTS
The family pedigree is illustrated in Fig. 1 . The families live in a remote area of North Wales where intermarriage is not uncommon. The two affected families in the present sixth generation share common ancestors. Two affected sisters, the proposita VI, 8 (case 1), and VI, 10 (case 2) are first cousins to an affected male VI, 11 (case 3), as their mothers V, 1 and 2 (cases 4 and 8) and father IV, 7 and 8 (cases 5 and 7), are sisters and brothers respectively. Each parent had married their distant cousin. The grandmother, III, 2 (case 12) of the affected sisters had married twice. Her second husband III, 3 was second cousin to the grandparents IV, 12 and 13 of the affected male. These grandparents were also first cousins. The second generation was not fully traced. In the present study three affected patients VI, 8, 10 , and 11 (cases 1, 2, and 3) and nine unaffected relatives, III, 2; IV, 6, 7, and 8; V, 1 and 2; VI, 9, 12, and 13 (cases 4-12) were investigated. Most members of the fourth, fifth, and sixth generations who were not examined, were questioned, and none complained of muscle symptoms.
CLINICAL METHODS
The following investigations were performed: haemoglobin, full blood count, blood urea and serum electrolytes, urinary myoglobin (after exercise), serum proteins and electrophoretic pattern, blood sugar, liver function tests, radiographs of the chest, and electrocardiography both before and after exercise, serum glutamic oxaloacetic and pyruvate transaminases (SGOT and SGPT) (Karmen, Wroblewski, and Ladue, 1955) , lactic acid dehydrogenase (LDH) (King, 1959) , aldolase and creatine phosphokinase (estimated by kit methods No. 750 and 661 respectively, provided by Sigma Chemical Company, St. Louis, U.S.A.), and plasma lactate (Barker and Summerson, 1941) after ischaemic muscle exercise (McArdle, 1951 (O'Brien and Ibbott, 1962) and myophosphorylase activity (Sutherland and Wosilait, 1956) Frozen sections Stains for glycogen showed some general excess, as against a normal control, and on the periphery of some fibres, sometimes within, and more often outside the sarcolemmal sheath, were collections of homogeneous material staining for glycogen. Digestion by amylase confirmed that this material was glycogen.
Muscle enzymes There was a complete absence of myophosphorylase as shown by histochemical staining technique but TPN and DPN diaphorases still showed the normal chequered staining pattern.
Cholinesterase staining showed mostly well-defined terminal expansions, though some were distorted and poorly stained. Staining took slightly longer than usual. Intravital methylene blue staining showed some irregularity of terminal expansions of motor nerve fibres some of which appeared rather distended, and some terminal nerve fibres showed slight varicosities. However some normal terminal innervation was seen.
Biochemical analysis of muscle No myophosphorylase activity was found, whereas a control rat muscle gave a normal assay. The glycogen content was 3-2 g/1CO g fresh muscle, the normal range being 0-2-09 g/l00 g. He was a first cousin of the proposita. This 17 year old farm worker had experienced weakness and stiffness in his limb muscles on exertion since early childhood. The milestones of infancy had been normal, but his parents had noticed that he had walked awkwardly since the age of 3. He had avoided games at school. Leg symptoms were aggravated by walking up several flights of stairs and he was unable to ride a bicycle. His symptoms were most marked in the mornings when he went immediately from his bed to work on the farm. They appeared less troublesome from mid-day, and he avoided symptoms by gradually increasing his activity. He was able to perform less strenuous tasks such as tractor driving without symptoms, whereas tossing hay would aggravate symptoms in his upper limbs.
Medical advice had not been sought, as his parents had considered that his condition, like that of his cousins, was untreatable.
He was of muscular build and clinically normal. The results of the relevant investigations were as follows: serum enzymes-serum aldolase 15 S-L u./ml.; serum creatine phosphokinase 41 sigma u./ml.; SGOT 7 u./ml.; SGPT 81 u./ml.; LDH 150 u./ml. The ischaemic lactate test showed a minimal rise (Fig. 2) (Fig.  3a) showed normal chequered distribution pattern. Myophosphorylase (Fig. 3b) was completely absent. Glycogen staining (Fig. 3c) showed an excess, mainly in blebs under the sarcolemmal sheath and occasionally outside the sheath. Intravital methylene blue showed no gross abnormality of motor nerve endings, although some branching in preterminal nerve fibres was seen, with occasional beaded fibres. Biochemical analysis of muscle: glycogen 1 53 g/100 g (control muscle 1-09 g/100 g). Phosphorylase-no activity detected (control rat muscle 120-5 ,u-mole/min/g, human control 96 5 ,L-mole/ min/g). CONCLUSION The most striking features were the absence of myophosphorylase and increase of glycogen. These features are diagnostic of myophosphorylase deficiency. The slight innervation changes were probably secondary.
TREATMENT Oral glucose relieved his muscular symptoms to some extent. A trial of fenfluramine (Ponderax, kindly supplied by Servier Labs Ltd, Harrow, M4iddx.) was made. This drug is used in the treatment of obesity and is thought to increase glucose uptake into muscle cells; 20 mg t.d.s. was given for four weeks, but no benefit was noted, and no significant weight loss occurred.
CASE 4
The unaffected 37 year old mother of cases 1 and 2. She had recently complained of tiredness on exertion, and had also experienced difficulty in climbing stairs due to low back pain. Clinically her symptoms were thought to be due to osteoarthritis of the lumbar spine, aggravated by obesity. A radiograph of the lumbar spine confirmed the diagnosis.
The results of the relevant investigations were as follows: serum enzymes-serum aldolase 10 S-L u./ml.; serum creatine phosphokinase 2 sigma u./ml.; SGOT 10 u./ml.; SGPT 10 u./ml.; LDH 200 u./ml. Urine-no myoglobin. The plasma lactate test showed a normal rise (Fig. 2) Biochemical analysis of muscle Glycogen 0 44 g/ 100 g (control rat muscle 1-09 g/100 g). Phosphorylase 37-9 ,L-mole/min/g (control rat muscle 120-5
,i-mole/min/g, human control 96-5 u-mole/min/g).
CONCLUSION
The muscle biopsy appearances suggest some denervation change. There was no evidence of myophosphorylase deficiency.
The eight other members of the families investigated showed no evidence of muscle disease ( Fig. 2 and Table) . Electromyographic investigation revealed normal records, and no silent 'contractures' were produced by ischaemic exercise. Repetitive maximal ulnar nerve stimulation produced less than 500 decrement in the evoked response in all subjects apart from case 9 who had a 69% fall. Dyken's test did not, therefore, clearly distinguish between the normal and affected cases. Several members of the families showed abnormal electroencephalograms irrespective of muscle disease. The abnormal features were excessive slow frequency activity within the delta and theta ranges. The proposita showed occasional spike formation. The slow activity in case 12 presumably reflected cerebral arteriosclerosis. Serum enzyme studies (Table) were normal in six of the eight apparently unaffected individuals. Two persons had slightly raised SGPT values, which are unexplained. (Schmid and Hammaker, 1961; Rowland, Fahn, and Schotland, 1963; Rowland, Lovelace, Schotland, Araki, and Carmel, 1966) . These studies have suggested that the disease has an autosomal recessive mode of inheritance. The genetic findings of the present study have confirmed the suggestion of a recessive inheritance, as the parents of the affected cases were apparently normal clinically and, in addition, other siblings were normal. It seems likely that intermarriage has favoured the expression of the trait in the two families. It is of interest that only eight of the 37 cases previously described were female. If the condition is an autosomal recessive then males and females ought to be equally affected. However, the deviation of the observed from the expected values is highly significant (x2 = 10-81 and P approximately 0.001). This marked male preponderance suggests the possibility of a sex-limited expression of an autosomal recessive character, although other explanations are also possible-for example, female homozygotes might be selectively eliminated over males during gestation. Classical X-linked recessive inheritance (for example, haemophilia) was not noted in this, or previous family studies.
An attempt to identify the heterozygous state by biochemical and muscle biopsy studies was not successful, although only one biopsy was performed on a clinically unaffected individual. Theoretically the parents of the affected cases should be carriers. A more extensive histochemical study of unaffected relatives (Bale, Muscle biopsy Histology Glycogen Phosphorylase
Hammett, and Neale, 1967) also failed to identify heterozygotes. The 'second wind phenomenon' has been noted in other cases (Pearson, Rimer, and Mommaerts, 1961) and has been investigated in some detail by Pernow, Havel, and Jennings (1967) who concluded that 'second wind' could be correlated with the level of free fatty acid (FFA) of arterial blood, although they did not demonstrate increased mobilization of FFA into the blood in these patients. In addition they showed that 'second wind' was associated with procedures which increased muscular blood flow.
A trial of fenfluramine hydrochloride, a drug usually employed in the treatment of obesity, was given to one of the affected cases. This drug is thought to increase glucose uptake into muscle cells (Butterfield and Whichelow, 1968) and also to increase the serum FFA level (Pawan, 1969) . However, no beneficial effect was noted. Yet all the affected cases obtained some relief by taking glucose or fructose before exercise, confirming the findings of other workers (Pearson et al., 1961) .
In contrast with the patients described by Schmid and Hammaker (1961) the muscle symptoms were not progressing in the three patients described in this paper and no muscle wasting was apparent; in fact, the lower limb girdle muscles seemed particularly well developed, suggesting compensatory hypertrophy.
In the present investigation the affected cases showed minimal or no rise in serum lactate after ischaemic exercise. Several clinically unaffected relatives showed smaller rises than the controls, but the standardization of the test does not allow one to conclude that these are partially affected cases.
The raised levels of muscle enzymes at rest are consistent with some permanent damage to the muscle cell membrane, as suggested by Nixon, Hobbs, and Greenblatt (1966) , and the changes in the muscle fibres seen on biopsy of case 1 would tend to confirm this.
The association of myophosphorylase deficiency with epilepsy has been noted previously and several theories have been propounded (Salmon and Turner, 1965) . The epileptic threshold may be reduced by circulating breakdown products of muscle. Epilepsy may be precipitated by hypoglycaemia caused by the excessive blood glucose utilization on exercise, due to the failure of muscle glycogen breakdown. The muscle breakdown and myoglobinuria are precipitated during the anoxia in the muscle stress of an epileptic attack, the two conditions being unrelated. However, in our cases blood sugar studies were normal in all, and none showed myoglobinuria at any time; we therefore concluded that our abnormal EEG findings might reflect an increased epileptic tendency in the inter-related families or, alternatively, there is a possibility that an intraneuronal enzyme could be coded by the same genome as myophosphorylase-that is, the epileptic tendency may be a pleiotrophic phenomenon.
The normality of the electromyograms in the affected cases during normal conditions of rest and exercise is in keeping with the findings of other workers (Hockaday, Downey, and Mottram, 1964) . Some observers have tended to believe that an electrically silent 'contracture' produced by exercise or evoked by repetitive stimulation of the motor nerve supply, is an invariable feature of this condition; this clearly is not the case. During the investigation of the families, the screening test described by Dyken, Smith, and Peake (1967) was used on the subjects, and also on a series of normal controls. The results show that the technique performed exactly as described by these workers does result in an appreciable drop in amplitude of the evoked response in normal subjects. A greater than 50%0 decrement in amplitude was not however seen in normal subjects with the exception of case 9 who showed a 69% decrement. The proposita and her clinically affected sister showed drops of 75%0 and 68% respectively, and the third affected patient, case 3, a 50%0 fall. There was therefore, no sharp division between normal and affected subjects.
ADDENDUM
Since this report was written, the proposita has married and has had a baby. Her normal progress in pregnancy and labour will be the subject of a further report.
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